Page 11 - Netscientific Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate announcements from NetScientific PLC, Price Monitoring Extension

The City broker pointed to the last fair value calculation for the assets held by the investment company, which specialises in life sciences and technology

    London, UK - 13 May 2021  - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) today announced an update on business, as well as financial results for the quarter ended 31 March 2021.   PDS Highlights for the Period: · National Cancer Institute to present interim efficacy and safety data of PDS0101 Phase 2 clinical trial in an oral presentation at the American Society of ...

    c. $60m Funding Commitment by Brazilian government for Clinical Development and Commercialisation of PDS Consortium's COVID-19 Vaccine   London, UK - 11 March 2021 - NetScientific plc (AIM: NSCI), the life sciences and sustainability technology investment and commercialisation Group, announces that PDS Biotech's proprietary Versamune®T-cell activating technology, today announced that its COVID-19 vaccine consortium jointly run by PDS consisting of Farmacore Biotechnology and Blanver Farmoquímica, has received a commitment from the Secretary for Research...

Investegate announcements from NetScientific PLC, Second Price Monitoring Extn